Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic : Challenges and opportunities
© American Society of Health-System Pharmacists 2021. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
PURPOSE: To share challenges and opportunities for antimicrobial stewardship programs based on one center's experience during the early weeks of the coronavirus disease 2019 (COVID-19) pandemic.
SUMMARY: In the spring of 2020, New York City quickly became a hotspot for the COVID-19 pandemic in the United States, putting a strain on local healthcare systems. Antimicrobial stewardship programs faced diagnostic and therapeutic uncertainties as well as healthcare resource challenges. With the lack of effective antivirals, antibiotic use in critically ill patients was difficult to avoid. Uncertainty drove antimicrobial use and thus antimicrobial stewardship principles were paramount. The dramatic influx of patients, drug and equipment shortages, and the need for prescribers to practice in alternative roles only compounded the situation. Establishing enhanced communication, education, and inventory control while leveraging the capabilities of the electronic medical record were some of the tools used to optimize existing resources.
CONCLUSION: New York City was a unique and challenging environment during the initial peak of the COVID-19 pandemic. Antimicrobial stewardship programs can learn from each other by sharing lessons learned and practice opportunities to better prepare other programs facing COVID-19 case surges.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists - 78(2021), 8 vom: 31. März, Seite 743-750 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kubin, Christine J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antimicrobial stewardship |
|---|
| Anmerkungen: |
Date Completed 12.04.2021 Date Revised 12.04.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/ajhp/zxaa419 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321038509 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321038509 | ||
| 003 | DE-627 | ||
| 005 | 20231225174948.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ajhp/zxaa419 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1070.xml |
| 035 | |a (DE-627)NLM321038509 | ||
| 035 | |a (NLM)33543233 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kubin, Christine J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic |b Challenges and opportunities |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.04.2021 | ||
| 500 | |a Date Revised 12.04.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © American Society of Health-System Pharmacists 2021. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a PURPOSE: To share challenges and opportunities for antimicrobial stewardship programs based on one center's experience during the early weeks of the coronavirus disease 2019 (COVID-19) pandemic | ||
| 520 | |a SUMMARY: In the spring of 2020, New York City quickly became a hotspot for the COVID-19 pandemic in the United States, putting a strain on local healthcare systems. Antimicrobial stewardship programs faced diagnostic and therapeutic uncertainties as well as healthcare resource challenges. With the lack of effective antivirals, antibiotic use in critically ill patients was difficult to avoid. Uncertainty drove antimicrobial use and thus antimicrobial stewardship principles were paramount. The dramatic influx of patients, drug and equipment shortages, and the need for prescribers to practice in alternative roles only compounded the situation. Establishing enhanced communication, education, and inventory control while leveraging the capabilities of the electronic medical record were some of the tools used to optimize existing resources | ||
| 520 | |a CONCLUSION: New York City was a unique and challenging environment during the initial peak of the COVID-19 pandemic. Antimicrobial stewardship programs can learn from each other by sharing lessons learned and practice opportunities to better prepare other programs facing COVID-19 case surges | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a antimicrobial stewardship | |
| 650 | 4 | |a drug utilization | |
| 650 | 4 | |a electronic medical record | |
| 700 | 1 | |a Loo, Angela S |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Nelson, Brian |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Monica |e verfasserin |4 aut | |
| 700 | 1 | |a Mazur, Shawn |e verfasserin |4 aut | |
| 700 | 1 | |a So, Wonhee |e verfasserin |4 aut | |
| 700 | 1 | |a Calfee, David P |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Harjot K |e verfasserin |4 aut | |
| 700 | 1 | |a Greendyke, William G |e verfasserin |4 aut | |
| 700 | 1 | |a Simon, Matthew S |e verfasserin |4 aut | |
| 700 | 1 | |a Furuya, E Yoko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists |d 1995 |g 78(2021), 8 vom: 31. März, Seite 743-750 |w (DE-627)NLM075145952 |x 1535-2900 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2021 |g number:8 |g day:31 |g month:03 |g pages:743-750 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ajhp/zxaa419 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2021 |e 8 |b 31 |c 03 |h 743-750 | ||